Brief S2k guidelines – Merkel cell carcinoma

Jurgen C. Becker, Chalid Assaf, Dirk Vordermark, Sven N. Reske, Jorg Hense, Therese Dettenborn, Oliver Seitz, Stephan Grabbe (1) Division of General Dermatology, Graz University Hospital, Austria (2) Department of Dermatology, HELIOS Klinikum, Krefeld, Germany (3) Department of Radiotherapy, University Hospital Halle (Saale), Germany (4) Department of Nuclear Medicine, University Hospital Ulm, Germany (5) Department of Internal Medicine, University Hospital Essen, Germany (6) Department of Plastic Surgery, Hornheide Clinic, Munster, Germany (7) Department of Oral and Maxillofacial Surgery, University of Frankfurt Hospital, Germany (8) Department of Dermatology, Mainz University Hospital, Germany

[1]  J. Medina,et al.  Merkel cell carcinoma of the head and neck , 2012, Head & neck.

[2]  D. Kraus,et al.  Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma , 2012, Cancer.

[3]  V. Gebski,et al.  Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. , 2012, Journal of the American Academy of Dermatology.

[4]  L. Misery,et al.  Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  C. Haglund,et al.  Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases. , 2012, European journal of cancer.

[6]  R. Miralbell,et al.  The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. , 2011, International journal of radiation oncology, biology, physics.

[7]  L. Fritschi,et al.  Merkel cell carcinoma in Western Australia: a population‐based study of incidence and survival , 2011, The British journal of dermatology.

[8]  B. Dréno,et al.  Treatment of a multicentric Merkel cell carcinoma using imatinib. , 2011, European journal of dermatology : EJD.

[9]  J. Salleron,et al.  Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. , 2011, Journal of the American Academy of Dermatology.

[10]  D. Schrama,et al.  Merkel cell carcinoma – pathogenesis, clinical aspects and treatment , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  D. Kraus,et al.  Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution , 2011, Annals of surgery.

[12]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[13]  S. Haferkamp,et al.  Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. , 2011, The Journal of investigative dermatology.

[14]  Jason S. Lewis,et al.  The next generation of positron emission tomography radiopharmaceuticals in oncology. , 2011, Seminars in nuclear medicine.

[15]  E. Guenova,et al.  Mapping of specific sentinel node locations for skin cancer of the head. , 2011, European journal of dermatology : EJD.

[16]  W. Hanna,et al.  Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma. , 2011, American journal of clinical pathology.

[17]  C. Bichakjian,et al.  Huntingtin Interacting Protein 1: a Merkel Cell Carcinoma Marker That Interacts with c-Kit , 2011, The Journal of investigative dermatology.

[18]  J. Messina,et al.  Prognostication in Merkel cell carcinoma , 2011, Expert review of anticancer therapy.

[19]  J. Holland,et al.  Successful strategies for implementing biopsychosocial screening , 2011, Psycho-oncology.

[20]  J. Schelter,et al.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Yu,et al.  Merkel cell carcinoma of skin-current controversies and recommendations , 2011, Rare tumors.

[22]  D. Kraus,et al.  Recurrence and Survival in Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: Analysis of 153 Patients from a Single Institution , 2011, Annals of Surgical Oncology.

[23]  Jennifer L. Schwartz,et al.  Features predicting sentinel lymph node positivity in Merkel cell carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  O. Visser,et al.  Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. , 2011, European journal of cancer.

[25]  N. Kübler,et al.  The new polyomavirus (MCPyV) does not affect the clinical course in MCCs. , 2010, International journal of oral and maxillofacial surgery.

[26]  V. Gebski,et al.  The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. , 2010, International journal of radiation oncology, biology, physics.

[27]  V. Sondak,et al.  Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. , 2010, Journal of the American Academy of Dermatology.

[28]  J. Lebeau,et al.  Remission of Merkel cell tumor after somatostatin analog treatment. , 2010, Journal of cancer research and therapeutics.

[29]  C. Hanke,et al.  Mohs micrographic surgery: Facts and controversies. , 2010, Clinics in dermatology.

[30]  J. Goedert,et al.  Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression , 2010, International journal of cancer.

[31]  P. Nghiem,et al.  Radiation monotherapy as regional treatment for lymph node‐positive Merkel cell carcinoma , 2010, Cancer.

[32]  M. Poulsen,et al.  Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb--a review of 60 cases. , 2010, International journal of radiation oncology, biology, physics.

[33]  C. Czerny,et al.  Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. , 2010, European journal of radiology.

[34]  D. Henson,et al.  Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study , 2010, Journal of cutaneous pathology.

[35]  S. Hewitt,et al.  Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. , 2009, International journal of radiation oncology, biology, physics.

[36]  N. Rao.  Review of the role of radiation therapy in the management of Merkel cell carcinoma. , 2010, Current problems in cancer.

[37]  J. Becker,et al.  The etiology and epidemiology of merkel cell carcinoma. , 2010, Current problems in cancer.

[38]  G. Larcos,et al.  The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. , 2010, Journal of the American Academy of Dermatology.

[39]  V. Sondak,et al.  The surgical management of primary and metastatic Merkel cell carcinoma. , 2010, Current problems in cancer.

[40]  M. Veness,et al.  Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: The Westmead Hospital experience and a review of the literature , 2009, The Australasian journal of dermatology.

[41]  B. Goh,et al.  Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  C. Slingluff,et al.  Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  H. Joensuu,et al.  Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. , 2009, Journal of the National Cancer Institute.

[44]  J. Becker,et al.  Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[45]  P. Vereecken,et al.  Management of Merkel tumours: an evidence-based review , 2008, Current opinion in oncology.

[46]  Arash Mostaghimi,et al.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.

[47]  H. Sandler,et al.  Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management , 2007, Cancer.

[48]  Jonathan R. Clark,et al.  Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary? , 2007, Head & neck.

[49]  M. Veness.  Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  H. Golan,et al.  FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan. , 2005, Nuclear medicine review. Central & Eastern Europe.

[51]  G. Strittmatter,et al.  Psychosoziale Betreuung von Patienten mit Hauttumoren in Zeiten der Diagnosis Related Groups (DRG) , 2004, Der Hautarzt.

[52]  U. Koch,et al.  Empfehlungen zur Psychoonkologischen Versorgung im Akutkrankenhaus , 2003 .